Mao et al. found that NDRG1 could be used as a marker for invasive breast cancer, observing that NDRG1 expression was significantly higher in invasive breast cancer versus matched non-tumor tissues, and its levels were associated with progression from breast atypia to carcinoma. Here, NDRG1 is linked to carcinoma.